SUMMARY ANSWER: Biochemical and clinical pregnancy diminish progressively as time between oocyte pick up (OPU) and ICSI increases after fresh embryo transfer.
Introduction
In the embryology laboratory, it is customary to wait for a certain period of time between oocyte pick up (OPU) and denudation (DN) , and between DN and ICSI, in the belief that the oocyte might need some time to recover after OPU, and to take full advantage of the presence of the somatic cell compartment in order to achieve its full developmental potential. However, this time can be different between laboratories and, within a laboratory, among patients. Furthermore, excessive postovulatory ageing might decrease the oocyte ability to support proper embryo development; in mice, postovulatory ageing induces alterations in gene expression, increases spindle abnormalities and the incidence of unaligned chromosomes, and modifies histone pattern in metaphase II (MII) oocytes (Trapphoff et al., 2016) . In humans, in vitro ageing has been linked to changes in the oocyte ultrastructure: decrease of mitochondria-smooth endoplasmic reticulum aggregates, increase in both size and number of mitochondria-vesicle complexes, decrease of cortical granules and microvilli, and alterations of the spindle structure (Bianchi et al., 2015) .
Incubation periods between 2 and 4 h between OPU and ICSI have been reported to improve oocyte maturation, fertilization rate and embryo quality (Rienzi et al., 1998; Ho et al., 2003; Isiklar et al., 2004) . Moreover, the number of oocytes with a visible spindle was lower 36-37 h post hCG compared with 38-39 and 40-42 h (Cohen et al., 2004) , and fertilization rates were higher in oocytes with a visible spindle compared with those where the spindle could not be visualized; Dozortsev (Dozortsev et al., 2004) found that the optimal insemination window for oocytes was 37-41 h post hCG. Other authors (Falcone et al., 2008) found that the optimal time for ICSI with respect to fertilization and pregnancy rates (PR) was 5-6 h after OPU (41-42 h post hCG). Nonetheless, other studies failed to identify an optimal time to perform ICSI after OPU (Van de Velde et al., 1998) , including when using donated oocytes (Barcena et al., 2016) .
Unfortunately, most studies were either performed in small samples, without a strict control of recorded timings, or in oocyte donors, making it difficult to reconcile the literature (Rubino et al., 2016) . The objective of the study was therefore to investigate in a large cohort of consecutive cases and automatically recorded timing, whether the time between OPU and DN, and OPU and ICSI, affect the laboratory and reproductive results in ART cycles.
Material and Methods

Study population and ethical approval
This is a retrospective consecutive cohort study including 1322 women undergoing 1468 ICSI cycles (80.0% first cycle) with a fresh embryo transfer (ET), performed at Clínica EUGIN between December 2012 and September 2015. The Ethics Committee for Clinical Investigation of the center approved the study.
Ovarian stimulation and laboratory procedures
Ovarian stimulation was induced with either Follitropin alpha (Gonal ® ,
Merck-Serono, Spain) or highly purified hMG (Menopur ® , Ferring, Spain), while pituitary suppression was achieved using GnRH antagosists (Cetrotide ® , Merck Serono Europe Limited, London, UK) fixed from the sixth day of ovarian stimulation or GnRH agonists (Decapeptyl ® , Ipsen Pharma, Spain) starting in the second phase of the preceding menstrual cycle. All ovulations were triggered with 250 μg hCG (Ovitrelle ® , Merck, Germany). Cumulus oocyte complexes (COCs) were retrieved 36 h post triggering by ultrasound-guided transvaginal follicular aspiration.
COCs were collected in buffered medium (G-MOPS ® PLUS, Vitrolife, Göteborg), containing Human Serum Albumin (HSA; Vitrolife, Göteborg); and then incubated at 37°C in 6% CO 2 and 95% relative humidity (RH) using culture medium containing HSA (IVF ® , Vitrolife, Göteborg). COCs were exposed to 80 IU/mL of hyaluronidase (HYASE-10× ® , Vitrolife, Göteborg) and mechanically removed by gentle pipetting in drops of buffered medium (G-MOPS® PLUS, Vitrolife, Göteborg) using capillaries of progressively smaller diameter (Flexi-Pet ® ; Cook Medicals, Bloomington, IN). MII oocytes were incubated at 37°C in 6% CO 2 and 95% RH in a specific medium (IVF ® , Vitrolife, Göteborg) until ICSI was performed. Immature oocytes in methaphase I (MI) were placed in the same conditions as MII but in another specific media (G2 ® , Vitrolife, Göteborg) to let them mature in vitro 4-8 h. If the maturation in vitro was completed, ICSI was performed.
Sperm samples were either donor samples (frozen) or partner samples (either fresh or frozen ejaculated sperm). Micro epididymal sperm aspiration (MESA) or testicular sperm extraction (TESE) cycles were excluded. Partner samples were frozen with cryoprotectant 1:1 v/v (Sperm CryoProtect II ® , Nidacon, Sweden). Sperm samples were collected or thawed the day of OPU, according to our protocol, fresh samples were requested 2 h after OPU, while frozen samples were thawed close to the end of DN. Samples were analyzed by SCA (Sperm Class Analyzer; Microptic), and graded according to the World Health Organization guidelines (WHO, 2010) . In order to minimize iatrogenic DNA damage to the sperm, sperm selection was performed by centrifugation at 1200 rpm for 10 min in 5 ml of sperm medium (PureSperm ® Wash, Nidacon, Sweden), followed by swim up at 27°C, 6% CO 2 and 95% RH (IVF ® , Vitrolife, Göteborg). ICSI was elective and performed routinely in all patients, using buffered media (G-MOPS ® PLUS, Vitrolife, Göteborg), polyvinylpyrrolidone (ICSI ® , Vitrolife, Göteborg) and a Narishigue (Narishigue Group, Japan) micromanipulator system. Only MII oocytes were injected, either the ones already obtained as MII after DN or the ones that were in MI stage at OPU and extruded the first polar body (1PB) before ICSI. In those cases, were MII and MI oocytes were obtained at OPU, ICSI was delayed to let MI mature in vitro. All the oocytes were treated in the laboratory following the same protocols and independently from the number of cycle of the patients. After ICSI, injected oocytes were placed in independent drops of 15 μl of culture medium (G1 ® , Vitrolife, Göteborg) covered with mineral oil (OVOIL ® , Vitrolife, Göteborg) and incubated at 37°C in 6% CO 2 and 95% RH.
Fertilization was assessed 14-19 h post ICSI. Embryo transfer was made at Day 2 or 3 and using hyaluronan-rich transfer medium (UTM ® , Origio, Denmark). Embryos were classified according to a modified scale based on the combined embryo score (Coroleu et al., 2006) , which takes into account number of blastomeres, percentage of embryo fragmentation and symmetry of the blastomeres with a maximum score of 10. Those embryos with a higher score were selected for ET, and the supernumerary embryos were vitrified the same day of the transfer. When frozen embryos were transferred, the thawing was done the same day of the cryotransfer.
Clinical procedures
The woman's endometrium was prepared for ET by administering 400 mg of progesterone (Utrogestan ® , SEID or Progeffik ® , Effik Laboratory) every 12 h vaginally. Progesterone was started the day of OPU and ended either the day of a negative pregnancy test, or 4 weeks later if positive. Clinical outcomes were evaluated: biochemical pregnancy (positive pregnancy test performed 14 days after the embryo transfer); clinical pregnancy (fetal heart beat observed at seventh week of gestation); ongoing pregnancy (adequately progressing pregnancy at 12 week of gestation) and live birth.
Timing control
A radiofrequency-based system (Witness ® , RI Ltd, UK) was used to record exact times automatically and independently from the operator, creating a detailed database of times. Laboratory times studied were: OPU-DN, DN-ICSI and OPU-ICSI, and the effect of total and partial time intervals between procedures, from OPU to ICSI, on fertilization rate and on biochemical, clinical, ongoing pregnancy and live birth rates were analyzed.
Statistical analysis
Descriptive statistics were performed for demographic variables and laboratory times for the 1468 ICSI cycles and separately for cycles where all oocytes obtained at OPU were mature ('MII group', n = 845), cycles where both MII and MI were obtained ('MIX group', n = 604) and cycles where only MI where obtained ('MI group', n = 19) ( Table I ).
Univariate differences in laboratory times between positive and negative biochemical, clinical and ongoing pregnancy, and positive and negative live birth were tested using Mann-Whitney U tests for the fresh ETs where transferred embryos were derived exclusively from oocytes that were MII at OPU. This was done to eliminate the bias of MI oocytes that extruded the 1PB in vitro. Moreover, we also calculated the cumulative pregnancy and the cumulative live birth rate, considering the fresh ET of embryos derived from MII oocytes at OPU and up to three subsequent frozen ETs of embryos derived from oocytes that were either MII at OPU or MI oocytes at OPU that matured in vitro.
To test the hypothesis of a linear trend (increasing or decreasing PR with time), we categorized laboratory times into 10 decile groups (Table II) , each decile containing the same number of cycles, and applied a linear-by-linear test.The effect of OPU-ICSI times on fertilization rate was modeled by a Generalized Linear Modeling (GLM) with woman's age and BMI, and sperm status and origin as covariates. Fertilization rates across OPU-ICSI times were also evaluated by means of Locally Weighted Scatterplot Smoothing (LOWESS) regression, with a fit to 50% of the points and an Epanechnikov weight function. The advantage of this regression is that it does not require the specification of a function to fit a model to all of the data in the sample, thus fitting to the data accurately across the whole range of time.
The effect of OPU-ICSI time on the size of the embryo cohort available (embryos transferred plus embryos vitrified) and on the morphological score of the embryos transferred was evaluated by non-parametric correlation (Spearman's rho). The likelihood of biochemical, clinical and ongoing pregnancy and live birth rates (for fresh ET) and biochemical pregnancy and live birth (for cumulative analyses) across OPU-ICSI times was evaluated by means of LOWESS and logistic regression, the latter adjusted by the following covariates: woman's age and BMI, number of embryos transferred, sperm origin and status, number of MII obtained at OPU and average morphological embryo score. For all the models an interaction term was included to test whether the effect of laboratory time on the pregnancy outcomes was modified by age. This interaction term was only kept in the final model if statistical significance was reached. Furthermore, we applied the same logistic regression model stratifying our group of patients according to the origin of the sperm (partner or donor).
Additionally, the effect of OPU-ICSI time on fertilization rate and pregnancy outcomes was evaluated using the same statistical approach in the subgroup of patients where only MII oocytes were obtained at OPU.The statistical package IBM SPSS 18.0 (New York, USA) and analyses Stata software v13.0 (Stata Corp., College Station, TX) were used to conduct all the statistical analyses. Statistical significance was set at P < 0.05.
Results
Baseline and cycle characteristics
The women included in the study were on 38.4 years old (SD 4.6) and had a BMI of 23.8 kg/m 2 (SD 4.2). Partner sperm was used in 56.7% of the cycles and donor sperm in 43.3%. Baseline characteristics and sperm parameters are described in Table I . The average number of COCs obtained at OPU per patient was 8.4 (SD 5.2, range: 1-34) from which 6.6 were MII (SD 4.2, range: 1-24). On average, 0.7 (SD 1.1) oocytes that extruded their 1PB after OPU were also inseminated. The mean fertilization rate was 70%, with 4.5 (SD 3.1, range: 1-19) fertilized oocytes (2PN) on average, resulting in 3.8 (SD 2.6, range: 1-17) embryos.
The number of embryos transferred was 1 (20% of cases), 2 (60%) or 3 (20%). Embryos were transferred on developmental Day 2 or 3 in 96.7% of cycles. The mean morphological score of transferred embryos was 7.7 (SD 1.3) on a 1-10 scale.
Laboratory times and effect of laboratory times on laboratory outcomes
All OPU were performed 36 h after hCG trigger. The mean times, in hours, for OPU-DN, DN-ICSI and OPU-ICSI were: 1.00 (SD 0.20, range: 0.42-2.12); 3.86 (SD 1.93, range: 0.26-11.19) and 4.87 (SD 1.96, range: 1.00-12.64). When stratifying by grade of maturity of the oocytes obtained at OPU, DN-ICSI and OPU-ICSI times were different among the groups, being longer if immature oocytes were obtained at OPU (Table I) .
Overall, we found a significant positive effect of OPU-ICSI time on fertilization rate (B = 0.052, 95% CI 0.022, 0.082; P < 0.001) that can be visualized in the LOWESS regression ( 
Effect of laboratory times on clinical outcomes
To eliminate the bias of oocytes that extruded the 1PB in vitro, results for clinical outcomes were calculated taking into account only those cycles where embryos coming from oocytes that were already MII at OPU were transferred (n = 1316). Biochemical, clinical and ongoing PR after the fresh ET were 39.6, 33.1 and 25.7%, respectively. Live birth rate was 21.6%. Cumulative values for biochemical pregnancy and live birth were 46.4 and 26.3%, respectively. None of the assayed laboratory times were different for cycles with positive or a negative biochemical, clinical or ongoing pregnancy outcomes, or with or without a live birth after the fresh ET (Table III) . Similar results were observed at cumulative analyses (Table IV) . The LOWESS regressions for biochemical, clinical and ongoing PR, and live birth rates across OPU-ICSI times shows a negative effect of time on biochemical pregnancy, which lessens as pregnancy evolves and disappears for live birth (Fig. 2) .
Analysis by time deciles and logistic regression analysis
The analysis by deciles of times ( Table V pregnancy after the fresh ET with longer OPU-ICSI times (P = 0.07). This finding reached significance when adjusting for potential confounders under the logistic regression model for the ETs where transferred embryos were derived exclusively from oocytes that were MII at OPU (n = 1316; P = 0.02) (Table VI) . This multivariable analysis showed that, on average (antilog transformed), each 1-h increase in the OPU-ICSI time reduced the likelihood of biochemical and clinical pregnancy by 7.3% (95% CI: 0.7-13.5%) and 7.7% (95% CI: 0.8-14.1%), respectively. No effect of time was observed for ongoing pregnancy or live birth rates. A similar decrease was observed for the DN-ICSI times: 7.5% (95% CI: 0.8-13.8%) for biochemical and 7.9% (95% CI: 1.0-14.4%) for clinical pregnancy; whereas OPU-DN time did not have any significant effect since the time intervals between OPU and DN were very stable across the database (0.5-2 h).
The cumulative analyses showed a decrease in biochemical pregnancy which did not reach significance, and no statistical difference for live birth (Table VII) . The multivariable analysis of all the cycles (n = 1468) showed similar results on clinical parameters: the OPU-ICSI time presented a negative statistically significant effect on biochemical and clinical pregnancy that was not maintained at ongoing pregnancy or live birth. The effect of time on pregnancy outcomes and live birth was not modified by age (i.e. the interaction term age × time was not statistically significant and was therefore excluded from the models).
Analysis stratified by sperm origin
The multivariable analysis stratified by origin of sperm evidenced the negative effect of OPU-ICSI time when partner sperm was used, but not with donor sperm: on average (anti-log transformed), each 1-h increase in the OPU-ICSI time reduced the likelihood of biochemical pregnancy by 10.3% (95% CI: 1.8-18.2%, P = 0.019) and 4.4% (95% CI: −4.5 to 12.6%, P = 0.32), respectively.
Analysis of the subgroup of patients were only MII oocytes were obtained at OPU When analyzing the 845 cycles where only MII were obtained at OPU (56.9% of cycles), the significant positive effect of OPU-ICSI time on fertilization rate was maintained (B = 0.076, 95%CI: 0.023-0.130; P = 0.005).
The multivariable analysis of these cycles showed similar results on clinical parameters to that performed with the whole cohort: the OPU-ICSI time presented a negative statistically significant effect on biochemical and clinical pregnancy that was not maintained at ongoing pregnancy or live birth (Table VIII) 
Discussion
The main finding in our study is that the longer the time between OPU and ICSI the lower the chances of pregnancy after both the transfer of fresh embryos, and when analyzing cumulative PR. The range in OPU-ICSI times that we could analyze was 1-12.5 h, i.e. 37-48.5 h post hCG .In agreement with our results, Yanagida et al. (1998) recommended to perform ICSI within 9 h from OPU (36-44 h post hCG). In fact, PR decreased significantly when more than 9 h elapsed (7.7 vs 15.9%). Others found that the clinical PR was higher within 2-6 h post OPU (37-41 h post hCG) and decreased thereafter (Dozortsev et al., 2004) . Finally, a higher clinical PR (35%) was obtained after an incubation time of 5-6 h after OPU (41-42 h post hCG) (Falcone et al., 2008) . Interestingly, some authors suggest that a minimum OPU-ICSI time is necessary to achieve better results. Rienzi et al. (1998) , studying timing groups from <3 h up to 12 h of culture before ICSI (<39-48 h post hCG), found lower fertilization rate and poorer embryo morphology when incubating the oocytes for <3 h. They postulate that an incubation period between OPU and ICSI might be necessary for the oocyte to reach cytoplasmic maturity but, when analyzing the clinical PR, the results did not seem to vary significantly among groups. This result is indeed in agreement with our own observation that fertilization rate increases with time in culture (see below), although we speculate that the purported improvement in laboratory outcomes is in fact a sign of oocyte ageing. Isiklar et al. (2004) reported that performing ICSI immediately after OPU (36 h post hCG) resulted in a lower implantation rate than after an incubation time for at least 2 h. The minimum time that we could study between OPU and ICSI was 1 h and, from then on, the PR decreased.
In a large study conducted on 3178 cycles with donated oocytes, i.e. from women aged 18-35 and assumed fertile, the time between OPU and ICSI did not have any impact on either fertilization or PR (Barcena et al., 2016) . All laboratory times in this last study were exactly and automatically controlled, and the lack of effect of timing point to an important role of the quality of the oocytes (either because of age or reproductive fitness) in withstanding the effects of in vitro ageing.
Although our results indicate a generalized decrease in oocyte developmental competence as in vitro culture progresses, we found an apparent paradoxical trend in fertilization rates, which increased with OPU-ICSI times. We reasoned that this could be due to one of two factors: improved cytoplasmic maturation over time or a higher propensity of the oocyte to be fertilized due to in vitro ageing.
Since we include in our database oocytes that extruded their 1PB within 4-8 h after collection, the increase of fertilization rate with time could be due to cytoplasmic maturation of immature oocytes with time. Alternatively, the increase in fertilization rate over time could be due to a stronger propensity for oocyte activation brought about by in vitro culture, which could lead to in vitro ageing.
On the one hand, the human oocyte cytoplasm continues to mature after the extrusion of the 1PB, and fertilization rate is higher if ICSI is performed 3-6 h after 1PB extrusion (Balakier et al., 2004) . Visualization of the 1PB should not be considered an indication of cytoplasm maturity per se (Neri et al., 2014) . In mouse, if ICSI is performed before the oocyte cytoplasm matures, resumption of meiosis might fail and pronuclei may not form (Kubiak, 1989) . Seeing that we include in our database oocytes that extruded their 1PB within 4-8 h after collection (as these oocytes can and do give rise to viable pregnancies and healthy births), and ICSI in our database was performed independently from the time from 1PB extrusion in these oocytes, a longer time from OPU to ICSI might result in higher developmental competence for these oocytes, increasing the fertilization rate of the pool, overall.
On the other hand, higher fertilization rates could be linked to in vitro ageing. Oocyte ageing is associated with changes in the M-phase promoting factor (MPF) and mitogen-activated protein kinase (MAPK) activity, both necessary to maintain meiotic arrest in metaphase II (Whitaker, 1996; Jiang et al., 2011) . Diminishing MAPK activity and MPF inactivation leads to one of the main manifestations of oocyte ageing: spontaneous activation (Petrova et al., 2004) . Aged oocytes with less MPF could be more easily activated by ICSI and form pronuclei, explaining the increase in fertilization with increasing OPU-ICSI times. To address the cause of the increase in fertilization rate, we analyzed the cycles where only MII oocytes were obtained (n = 845). Since ICSI was performed, on average, 4.9 h post OPU, most MII oocytes were likely to have mature cytoplasm and a visible spindle and, consequently, adequate chances to fertilize. However, this analysis returned the same results: the longer the OPU-ICSI time, the higher the fertilization. We further reasoned that an increase in fertilization rate due to in vitro ageing should not be related to an increase in embryo score and an improvement of the embryo capacity to give a pregnancy. Accordingly, we found that the morphology of the embryos transferred and the availability of embryos were similar regardless of the time between OPU and ICSI. Thus, the increase in fertilization was not clinically relevant, as the number of embryos available for transfer remained unchanged. Another factor that could influence the results is the incubation time of prepared sperm before ICSI. Nabi et al. (2014) found that incubation of prepared semen at 37°C for 2 or 3 h caused more sperm DNA fragmentation compared to the same samples without incubation. In our study we could not analyze the time from sperm preparation to ICSI, and how it might have affected the results; nevertheless, the sperm preparation protocol was designed specifically to minimize the induction of sperm DNA fragmentation: first of all, we use pellet swim up to prepare sperm, as it has been found that this technique induces less DNA fragmentation than direct swim up or density gradients (Volpes et al., 2016) . Secondly, samples are incubated at 27°C instead of 37°C to decrease enzymatic activity. Thirdly, our population undergoes ICSI electively, while it has been shown that DNA fragmentation is more likely to be a factor in semen of poor quality with an indication for ICSI. Nevertheless, we cannot exclude an effect of incubation time of prepared sperm on PR, and this should be taken into account when interpreting our results. Our study presents several strengths compared with the available literature, including the selection of a large population of infertile couples, and the exact, automated, and operator independent recording of all laboratory times. Another strength is the inclusion of cumulative results. Although the analysis of cumulative pregnancy did not reach statistical significance, it pointed in the same direction of the results obtained analyzing fresh ETs and this reinforces our conclusions, indicating that the OPU-ICSI time does have an effect on the cohort of oocytes collected, and not just on the embryos that are transferred on the first attempt. Nevertheless, we recognize that not all variables affecting reproductive outcomes can be taken into account, and the lack of significant finding in live birth rates warrants further investigation.
In conclusion this study indicates that in vitro ageing of human oocytes significantly affects the chance of becoming pregnant. Effect on live birth rates, although not evident in this study, cannot be excluded. According to our findings, ICSI should not be delayed whenever possible, while keeping in mind that the decrease we have encountered in PR are averages, and that the time to ICSI might affect couples differently according to diagnosis, age and other unaccounted-for factors.
